Jump to main content
Jump to site search

Issue 47, 2018
Previous Article Next Article

Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic D,L-α-peptide conformational inhibitor

Author affiliations

Abstract

Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic D,L-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.

Graphical abstract: Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Feb 2018, accepted on 14 May 2018 and first published on 16 May 2018


Article type: Communication
DOI: 10.1039/C8CC01233D
Citation: Chem. Commun., 2018,54, 5980-5983
  •   Request permissions

    Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic D,L-α-peptide conformational inhibitor

    A. Belostozky, M. Richman, E. Lisniansky, A. Tovchygrechko, J. H. Chill and S. Rahimipour, Chem. Commun., 2018, 54, 5980
    DOI: 10.1039/C8CC01233D

Search articles by author

Spotlight

Advertisements